SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. (2010)
Attributed to:
Core support for collaborative glycomic and proteomic research
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2010.9
PubMed Identifier: 20147977
Publication URI: http://europepmc.org/abstract/MED/20147977
Type: Journal Article/Review
Volume: 24
Parent Publication: Leukemia
Issue: 4
ISSN: 0887-6924